Home・Akcijų sąrašas・Embecta Corp

Embecta Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

4.42 26.65

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.51

Max

4.68

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-48M -4.1M
Pardavimai	-39M 222M
P/E Sektoriaus vid.	1.928 68.51
Pelnas, tenkantis vienai akcijai	0.27
Dividendų pajamingumas	16.48
Pelno marža	-1.849
Darbuotojai	1,850
EBITDA	-51M 45M

Rekomendacijos
By TipRanks
Rekomendacijos	Parduoti
12 mėnesių prognozė	-14.29% downside

Dividendai
By Acuity
Dividendų pajamingumas Sektoriaus vid.	16.48% 2.29%
Kitas uždarbis	2026-08-07
Kitas dividendų mokėjimo data	2026-09-15
Kita Ex Dividend data	2026-08-27

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-327M 221M
Ankstesnė atidarymo kaina	-22.23
Ankstesnė uždarymo kaina	4.42

Naujienos nuotaikos

By Acuity

72%

28%

308 / 340 reitingas Healthcare

Embecta Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-06 23:42; UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

2026-08-05 22:36; UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

2026-08-04 19:26; UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

2026-08-03 20:03; UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

2026-07-31 21:02; UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

2026-07-30 21:02; UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

2026-07-29 19:04; UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

2026-07-28 22:01; UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

2026-07-27 18:03; UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

2026-07-24 21:31; UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

2026-07-22 18:02; UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

2026-07-21 23:01; UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

2026-07-20 19:52; UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Akcijų palyginimas

Kainos pokytis

Embecta Corp Prognozė

Kainos tikslas

By TipRanks

-14.29% į apačią

12 mėnesių prognozė

Vidutinis 3 USD -14.29%

Aukščiausias 3 USD

Žemiausias 3 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Embecta Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Parduoti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Embecta Corp akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

308 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.